3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine

3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine Struktur
1270744-79-0
CAS-Nr.
1270744-79-0
Englisch Name:
3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine
Synonyma:
3-(piperidin-3-yl)-5-propyl-1,2,4-oxadiazole;3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine;Piperidine, 3-(5-propyl-1,2,4-oxadiazol-3-yl)-
CBNumber:
CB42535254
Summenformel:
C10H17N3O
Molgewicht:
195.26
MOL-Datei:
1270744-79-0.mol

3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine Eigenschaften

Siedepunkt:
323.9±52.0 °C(Predicted)
Dichte
1.054±0.06 g/cm3(Predicted)
pka
8.77±0.10(Predicted)

Sicherheit

3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine Chemische Eigenschaften,Einsatz,Produktion Methoden

3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 11)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63711 58
Career Henan Chemica Co
+86-0371-86658258 +8613203830695
laboratory@coreychem.com China 30250 58
Dayang Chem (Hangzhou) Co.,Ltd.
571-88938639 +8617705817739
info@dycnchem.com China 52861 58
PT CHEM GROUP LIMITED

peter68@ptchemgroup.com China 35426 58
GIHI CHEMICALS CO.,LIMITED
+8618058761490
info@gihichemicals.com China 50003 58
Hangzhou Sage Chemical Co., Ltd. +86057186818502 13588463833
info@sagechem.com China 10269 58
Grader reagent 18221735425
sales@xinpingchem.com China 9951 58
Adobe Chem Co., Ltd. 2332782371
adobechem@qq.com China 7980 58
Chengdu Saiousi Pharmaceutical Co., Ltd 028-64971018 18108168130
China 1781 55
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946
1461866103@qq.com China 16111 58

  • 3-(5-Propyl-[1,2,4]oxadiazol-3-yl)-piperidine
  • 3-(piperidin-3-yl)-5-propyl-1,2,4-oxadiazole
  • Piperidine, 3-(5-propyl-1,2,4-oxadiazol-3-yl)-
  • 1270744-79-0
Copyright 2019 © ChemicalBook. All rights reserved